As the flu and respiratory virus continue to wreak havoc across the country, over-the-counter (OTC) cold and cough medicine brands are boosting their ad spend in an attempt to capture market share at a time of heightened consumer attention. In October, OTC cold and cough brands spent $41 million on advertising, 62% more than in October of 2021, according to data from MediaRadar, an advertising intelligence platform. In addition, MediaRadar found that October ad spend in the category was up nearly 30% over September.
“This is exactly the time to advertise,” said Markus Saba, a marketing professor focusing on health care at the University of North Carolina. “You’re fighting for share of market, the demand has come and you have a chance to make up for the last two years’ loss of share with COVID when there was no market.”